374753-00-1

Basic information

• Product Name: (4S,5R)-3-[(2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptanoyl]-4-methyl-5-phenyl-oxazolidin-2-one
• Synonyms: (4S,5R)-3-[(2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptanoyl]-4-methyl-5-phenyl-oxazolidin-2-one
• CAS NO: 374753-00-1
• Molecular Weight: 605.728
• Mol File: 374753-00-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (4S,5R)-3-[(2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptanoyl]-4-methyl-5-phenyl-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (4S,5R)-3-[(2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptanoyl]-4-methyl-5-phenyl-oxazolidin-2-one(374753-00-1)
• EPA Substance Registry System: (4S,5R)-3-[(2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptanoyl]-4-methyl-5-phenyl-oxazolidin-2-one(374753-00-1)

Safety Data

• Hazardous Substances Data: 374753-00-1(Hazardous Substances Data)

Upstream product

• 77877-20-4 (4S,5R)-4-methyl-5-phenyl-3-propionyloxazolidin-2-one 
• 374752-76-8 (2R,3S)-3-Benzyloxymethoxy-5-(4-methoxy-benzyloxy)-2-methyl-pentanal 
• 492-41-1 (1R,2S)-norephedrine 
• 128461-65-4 3-(p-methoxybenzyloxy)propanal 
• 152330-77-3 (2R,3S)-3-hydroxy-N-methoxy-5-(4-methoxybenzyloxy)-N,2-dimethylpentanamide 
• 129985-91-7 <3(2R,3S),4R,5S>-3-<3-hydroxy-5-<(4-methoxyphenyl)methoxy>-2-methyl-1-oxopentyl>-4-methyl-5-phenyl-2-oxazolidinone 
• 201993-96-6 (2R,3S)-3-Benzyloxymethoxy-5-(4-methoxy-benzyloxy)-2-methyl-pentanoic acid methoxy-methyl-amide 
• 16251-45-9 (4S,5R)-4-methyl-5-phenyl-oxazolidin-2-one 

Downstream Products

• 482626-40-4 (2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptanoic acid methyl ester 
• 482626-38-0 (4S,5R,6S,7R,8S)-6-Benzyloxy-8-benzyloxymethoxy-10-(4-methoxy-benzyloxy)-5,7-dimethyl-dec-1-en-4-ol 
• 374753-02-3 (2S,3R,4S,5S)-5-Benzyloxymethoxy-3-hydroxy-2,4-dimethyl-7-triisopropylsilanyloxy-heptanoic acid methyl ester 
• 482626-41-5 (2S,3R,4S,5S)-5-Benzyloxymethoxy-3,7-dihydroxy-2,4-dimethyl-heptanoic acid methyl ester 
• 482626-53-9 C₄₄H₅₀O₁₁S 
• 482626-52-8 C₄₇H₅₂O₁₀S 
• 374752-85-9 C₄₈H₅₄O₉ 
• 482626-55-1 (R)-2-{(2R,5S)-5-[(1R,2R,3R,4R)-2-Benzyloxy-1,3-dimethyl-4-((E)-3-oxo-hex-1-enyloxy)-6-(toluene-4-sulfonyloxy)-hexyl]-tetrahydro-furan-2-yl}-propionic acid methyl ester 
• 374752-87-1 C₃₉H₄₄O₉S 
• 374752-89-3 C₃₇H₄₃IO₈ 
• 482626-51-7 C₄₀H₄₆O₈ 
• 374752-91-7 C₃₇H₄₄O₈ 
• 374752-79-1 [(2R,3S,4R,5S)-3-Benzyloxy-5-benzyloxymethoxy-7-(4-methoxy-benzyloxy)-2,4-dimethyl-heptyloxy]-tert-butyl-dimethyl-silane 
• 482626-39-1 (3R,4R,5S,6R,7S)-5-Benzyloxy-7-benzyloxymethoxy-9-(4-methoxy-benzyloxy)-4,6-dimethyl-nonane-1,3-diol 

Relevant articles and documents

Stereoselective synthesis of pamamycin-607

A macrodiolide antibiotic pamamycin-607 was synthesized by joining two hydroxy acid components. Three cis-2, 5-disubstituted tetrahydrofuran rings in the molecule were stereoselectively prepared by radical cyclization reactions of β-alkoxyvinyl ketone intermediates and a β-alkoxymethacrylate substrate. The key step of the synthesis is characterized by the predominant threo product formation in the radical cyclization reaction of a β-alkoxymethacrylate intermediate.